Eldridge Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $287K | Hold |
708
| – | – | 0.06% | 138 |
|
|
2025
Q1 | $352K | Hold |
708
| – | – | 0.08% | 129 |
|
|
2024
Q4 | $368K | Hold |
708
| – | – | 0.09% | 120 |
|
|
2024
Q3 | $438K | Hold |
708
| – | – | 0.1% | 115 |
|
|
2024
Q2 | $392K | Buy |
708
+3
| +0.4% | +$1.66K | 0.1% | 111 |
|
|
2024
Q1 | $410K | Buy |
705
+7
| +1% | +$4.07K | 0.11% | 111 |
|
|
2023
Q4 | $371K | Hold |
698
| – | – | 0.1% | 112 |
|
|
2023
Q3 | $353K | Sell |
698
-80
| -10% | -$40.5K | 0.12% | 106 |
|
|
2023
Q2 | $406K | Hold |
778
| – | – | 0.13% | 98 |
|
|
2023
Q1 | $448K | Hold |
778
| – | – | 0.16% | 86 |
|
|
2022
Q4 | $428K | Buy |
778
+50
| +7% | +$27.5K | 0.15% | 88 |
|
|
2022
Q3 | $369K | Hold |
728
| – | – | 0.14% | 95 |
|
|
2022
Q2 | $396K | Hold |
728
| – | – | 0.15% | 85 |
|
|
2022
Q1 | $430K | Hold |
728
| – | – | 0.15% | 85 |
|
|
2021
Q4 | $486K | Hold |
728
| – | – | 0.16% | 81 |
|
|
2021
Q3 | $416K | Hold |
728
| – | – | 0.15% | 80 |
|
|
2021
Q2 | $367K | Hold |
728
| – | – | 0.13% | 85 |
|
|
2021
Q1 | $332K | Hold |
728
| – | – | 0.13% | 86 |
|
|
2020
Q4 | $339K | Hold |
728
| – | – | 0.14% | 78 |
|
|
2020
Q3 | $321K | Sell |
728
-6
| -0.8% | -$2.65K | 0.15% | 72 |
|
|
2020
Q2 | $266K | Buy |
734
+6
| +0.8% | +$2.17K | 0.13% | 80 |
|
|
2020
Q1 | $206K | Hold |
728
| – | – | 0.12% | 85 |
|
|
2019
Q4 | $237K | Hold |
728
| – | – | 0.12% | 85 |
|
|
2019
Q3 | $212K | Hold |
728
| – | – | 0.11% | 91 |
|
|
2019
Q2 | $214K | Buy |
+728
| New | +$214K | 0.11% | 81 |
|